Actuate Therapeutics, Inc Common stock
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -5,402 | -5,944 | -6,311 | -6,322 |
EBIT | -5,968 | -12,731 | -6,441 | |
Net Income | -5,407 | -5,949 | -6,317 | -6,446 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,677 | -4,348 | -4,618 | -4,772 |
Cash | 16,924 | 6,492 | 3,889 | 8,641 |
Basic Shares | 21,394 | 19,646 | 19,497 | 19,514 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -25,160 | -24,428 | -20,079 |
EBIT | -27,304 | -24,700 | -20,143 |
Net Income | -27,285 | -24,744 | -20,159 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -21,842 | -21,625 | -17,794 |
Cash | 8,641 | 2,958 | 20,449 |
Basic Shares | 19,514 | 15,033 | 15,033 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.25 |
2025-06-30 | -$0.30 |
2025-03-31 | -$0.32 |
2024-12-31 | -$0.33 |
